Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-130174
Filing Date
2024-11-22
Accepted
2024-11-22 16:01:57
Documents
2
Period of Report
2024-11-06

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 2468
2 EX-24 kpti-ex24.htm EX-24 8091
  Complete submission text file 0000950170-24-130174.txt   12014
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Issuer) CIK: 0001503802 (see all company filings)

EIN.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O KARYOPHARM THERAPEUTICS INC. 85 WELLS AVENUE NEWTON MA 02459
Business Address
Abate Kristin (Reporting) CIK: 0002045943 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36167 | Film No.: 241489605